(Q43793424)

26 November 2017

IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization (English)

1 reference

26 November 2017

1 reference

1 reference

Zurbriggen R

1

1 reference

26 November 2017

Novak-Hofer I

series ordinal

2

1 reference

26 November 2017

Seelig A

series ordinal

3

1 reference

26 November 2017

Glück R

series ordinal

4

1 reference

26 November 2017

1 January 2000

1 reference

Progress in Lipid Research

26 November 2017

1 reference

26 November 2017

39

1 reference

26 November 2017

1

1 reference

26 November 2017

3-18

1 reference

Adjuvants--a balance between toxicity and adjuvanticity

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Incomplete neutralization of hepatitis A virus in vitro due to lipid-associated virions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Biophysical and Biochemical Characterization of Hepatitis A Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Hepatitis A Virus Attachment to Cultured Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Structure of the hepatitis A virion: identification of potential surface-exposed regions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

The Physicochemical Properties of Infectious Hepatitis A Virions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Local anesthetics and pressure: a comparison of dibucaine binding to lipid monolayers and bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

The polypeptide composition of influenza A viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Molecular determinants of the reversible membrane anchorage of the G-protein transducin.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Streptavidin in antibody pretargeting. 2. Evaluation Of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

T cell priming versus T cell tolerance induced by synthetic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

A Theory of Self-Nonself Discrimination: Paralysis and induction involve the recognition of one and two determinants on an antigen, respectively

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

A new analysis of allogeneic interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

Current status of immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7827%2899%2900017-X

7 January 2021

10.1016/S0163-7827(99)00017-X

Identifiers

DOI

1 reference

26 November 2017

1 reference